BCPC opposes arbitrary pesticide reduction targets    qrcode

FavoritesPrint
Forward
May. 6, 2010


BCPC has issued a comprehensive response to Defra’s recent Consultation on the implementation of EU pesticides legislation, highlighting some 40 key points and focussing in particular on risk assessment, water protection, research and education.

Completely opposing the introduction of a pesticide reduction target, BCPC feels that pesticide policy in the UK should continue to focus on limiting pesticide use to the minimum necessary to provide effective control and reduce identified risks to human health or the environment. Some EU Members States having already set arbitrary pesticide reduction targets, but BCPC has consistently argued against such an illogical and unscientific approach. It asserts that it is the method, timing and frequency of application that are the key determinants of risk, rather than the amounts of product or active ingredients used.

In this context, BCPC is not in favour of prohibiting the use of pesticides in public and conservation areas. With the appropriate risk assessments already built into the product approval process, it regards minimising use as being a far more cost-effective approach than looking to develop alternative control methods for weed, pests and disease control. Similarly, unless specified in the product’s approval, it feels that signage – where the public has access to sprayed areas – is inappropriate and may even cause unnecessary alarm.

With regards to the proposals on water protection, BCPC favours building on existing measures developed under the Voluntary Initiative. It points out that this approach will require significant R&D and special attention will also need to be given to developing specific guidance for some amenity situations and improving labelling of relevant products.

"We have referred to the need for R&D several times in our response and we believe that this is a crucial area which needs to be revitalized in the UK in the future,” says Dr Colin Ruscoe, chairman of BCPC. “As well as providing advanced level training for practitioners, we need to deal with the current lack of good quality crop protection specialists, who are needed to undertake the necessary R&D so that UK pesticide policy can be implemented in the most effective way. This is a critical requirement if we are to deliver sustainable increases in food production in the face of both demand and the reducing armoury of crop protection products resulting from EU legislation.”

 

Source: BCPC

Recommended Events

Popular speakers

Bill Duan

General Manager

Leili Marine BioIndustry INC.

Li Qian

Biocontrol product development manager

Syngenta Biologicals

Romy Ursúa Monreal

CEO

IKAN Consultores

Romy is a regulatory and legal expert with more than 13 years of experience in Mexico’s crop protection and biologicals industry. As CEO of IKAN Consultores, part of the LATAM Regulatory Network, she defines the firm’s strategic vision and leads the development of regulatory and compliance strategies that help national and international clients achieve market access and regulatory alignment across Latin America. She also serves as Chair of the Crop Protection Commission at the Mexican Association of Professionals in Health Regulation (AMEPRES). Her leadership has positioned IKAN as a strategic partner for national and international companies seeking to operate within complex regulatory frameworks in Mexico and Latin America. Romy holds a Law degree, postgraduate studies in Administrative and Health Law, and a diploma in Customs Administration from Tecnológico de Monterrey, strengthening her focus on trade, regulatory compliance, and customs management.

Dr. Rao Chitong

Partner and Chief Scientist

Bluepha

• Bachelor of Science in Biology, Peking University; Ph.D. in Microbiology, University of Toronto; Postdoctoral Fellow in Microbiome Research, Harvard Medical School. • Published over 20 papers in top-tier international journals such as Natureand Cell. • Awarded the 2021 National Award for Outstanding Self-Financed International Students. • Recipient of the 2021 Distinguished Research Award from the Chinese Scholars and Experts Association at Harvard Medical School. • Awarded the 2022 National-Level Overseas Young Talents Project; previously served as an Associate Professor at the Health Science Center of Peking University before joining Bluepha as a full-time Chief Scientist. • Recipient of the 2023 Shanghai Magnolia Talent Program. • Awarded the 2024 Shanghai Science and Technology Rising Star Program.